Chronic Airflow Limitation, Emphysema and Impaired Diffusing Capacity in Relation to Smoking Habits in a Swedish Middle-Aged Population
Anders Blomberg,Kjell Torén,Per Liv,Gabriel Granåsen,Anders Andersson,Annelie Behndig,Göran Bergström,John Brandberg,Kenneth Caidahl,Kerstin Cederlund,Arne Egesten,Magnus Ekström,Maria J Eriksson,Emil Hagström,Christer Janson,Tomas Jernberg,David Kylhammar,Lars Lind,Anne Lindberg,Eva Lindberg,Claes-Göran Löfdahl,Andrei Malinovschi,Maria Mannila,Lars T Nilsson,Anna-Carin Olin,Anders Persson,Hans Lennart Persson,Annika Rosengren,Johan Sundström,Eva Swahn,Stefan Söderberg,Jenny Vikgren,Per Wollmer,Carl Johan Östgren,Jan Engvall,C Magnus Sköld
DOI: https://doi.org/10.1513/AnnalsATS.202402-122OC
2024-08-12
Abstract:Rationale: Chronic obstructive pulmonary disease (COPD) includes respiratory symptoms and chronic airflow limitation (CAL). In some cases, emphysema and impaired diffusing capacity for carbon monoxide (DLCO) are present, but characteristics and symptoms vary with smoking exposure. Objectives: To study the prevalence of CAL, emphysema and impaired DLCO in relation to smoking and respiratory symptoms in a middle-aged population. Methods: We investigated 28,746 randomly invited individuals (52% women) aged 50-64 years across six Swedish sites. We performed spirometry, DLCO, high-resolution computed tomography (HRCT) and asked for smoking habits and respiratory symptoms. CAL was defined as post-bronchodilator forced expiratory volume in 1 second divided by forced expiratory volume (FEV1/FVC)<0.7. Results: The overall prevalence was for CAL 8.8%, for impaired DLCO (DLCO<LLN) 5.7% and for emphysema 8.8%, with a higher prevalence in current smokers than in ex-smokers and never-smokers. The proportion of never-smokers among those with CAL, emphysema and impaired DLCO was 32%, 19% and 31% respectively. Regardless of smoking habits, the prevalence of respiratory symptoms was higher among people with CAL and impaired DLCO, compared to those with normal lung function. Asthma prevalence in never-smokers with CAL was 14%. In this group, asthma associated with lower FEV1 and more respiratory symptoms. Conclusions: In this large population-based study of middle-aged people, CAL and impaired DLCO were associated with common respiratory symptoms. Self-reported asthma was not associated with CAL in never-smokers. Our findings suggest that CAL in never-smokers signifies a separate clinical phenotype that may be monitored and, possibly, treated differently from smoking-related COPD. This article is open access and distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).